Home > Income Statement > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
Consolidated Net Profit

    Back to Income Statement
EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for EMCURE PHARMACEUTICALS
Please provide your vote to see the results

EMCURE PHARMACEUTICALS Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹681 Cr₹498 Cr₹532 Cr₹662 Cr₹392 Cr

What is the latest Consolidated Net Profit of EMCURE PHARMACEUTICALS ?

The latest Consolidated Net Profit ratio of EMCURE PHARMACEUTICALS is ₹681 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹681 Cr
Mar2024₹498 Cr
Mar2023₹532 Cr
Mar2022₹662 Cr
Mar2021₹392 Cr

How is Consolidated Net Profit of EMCURE PHARMACEUTICALS Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹681 Cr
36.76
Mar2024 ₹498 Cr
-6.36
Mar2023 ₹532 Cr
-19.66
Mar2022 ₹662 Cr
68.87
Mar2021 ₹392 Cr -

Compare Consolidated Net Profit of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹34,344.2 Cr -1.2% 4.7% 41.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹464,331.0 Cr 1.2% 8.3% 15.5% Stock Analytics
DIVIS LABORATORIES ₹181,466.0 Cr -0.2% 3% -0.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹165,952.0 Cr 1.7% 9.9% 46.8% Stock Analytics
CIPLA ₹116,229.0 Cr -2.2% 4.5% -4.4% Stock Analytics
DR REDDYS LABORATORIES ₹103,959.0 Cr -9% -2.1% -1.8% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

-1.2%

4.7%

41.2%

SENSEX

-0.3%

4.9%

-7%


You may also like the below Video Courses